ELAVL1 and cystic fibrosis: Nonetheless, these results establish, for the first time, the therapeutic potential of HuR-targeted small molecules as host-directed agents against P. aeruginosa infection, and support the development of (2S,3S)-BOPC derivatives for preventing or reducing bacterial colonization in CF lungs.